Nature's Sunshine Products (NATR) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Nature's Sunshine Products is the larger company by market cap ($176.4 million vs $176.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NATR | VOGX |
|---|---|---|
| Share price | $10.18 | $11.87 |
| Market cap | $176.41M | $176.33M |
| 1-day change | +0.10% | -7.30% |
| YTD return | -52.83% | — |
| 1-year return | -51.84% | — |
| 5-year return | -40.40% | — |
| P/E ratio (TTM) | 12.41 | — |
| Forward P/E | 10.77 | — |
| EPS (TTM) | $0.82 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $480.14M | — |
| Revenue growth (YoY) | +5.67% | — |
| Net income (latest FY) | $19.52M | — |
| Gross margin | 72.42% | — |
| Operating margin | 5.15% | — |
| Net margin | 4.07% | — |
| 52-week high | $28.14 | $38.41 |
| 52-week low | $9.38 | $11.51 |
| Distance from 52-week high | -63.82% | -69.10% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +62.08% | +363.35% |
| Average volume | 168.24K | 128.78K |
| Shares outstanding | 17.33M | 14.86M |
| Employees | 806 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
NATR vs VOGX FAQ
Which is bigger, Nature's Sunshine Products or Vogenx?
Nature's Sunshine Products (NATR) is larger, with a market capitalization of $176.41M compared with $176.33M for Vogenx (VOGX).
Are Nature's Sunshine Products and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.